Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 100 of 131 entries
View as:

Post-Authorization Long-term Safety Surveillance on Antihypertensive Treatment With Kanarb® (Fimasartan)

Phase: N/A Priority: Normal
NCT ID: NCT02385721 Org: User:
Start: 05/31/13 End: 04/30/18 Due: 04/30/19

A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015 and Co-administration of BR1015-3 and BR1015-2 Under Fed Conditions

Phase: N/A Priority: Normal
NCT ID: NCT06744439 Org: User:
Start: 01/09/25 End: 03/16/25 Due: 03/16/26

Pharmacokinetics of Megace F and Megace OS Under Fasting and Fed Conditions in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01397214 Org: User:
Start: 07/31/11 End: 01/31/12 Due: 01/31/13

A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015 and Co-administration of BR1015-3 and BR1015-2 Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT06744426 Org: User:
Start: 01/04/25 End: 03/12/25 Due: 03/12/26

A Clinical Trial to Compare the Pharmacokinetics and Safety of "BR1016A" With "BR1016B" in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT05102903 Org: User:
Start: 10/22/21 End: 12/14/21 Due: 12/14/22

A Multi-center,Prospective, OS to Evaluate the Effectiveness of 'NAC' Nebulizer Therapy in COPD (NEWEST)

Phase: N/A Priority: Normal
NCT ID: NCT05102305 Org: User:
Start: 09/09/21 End: 11/29/22 Due: 11/29/23

A Study to Evaluate Drug-drug Interactions Between BR1017-1 and BR1017-2 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT05372380 Org: User:
Start: 05/09/22 End: 06/30/22 Due: 06/30/23

A Clinical Trial to Compare the Pharmacokinetics and Safety of "BR1016C" With "BR1016D" in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT05102266 Org: User:
Start: 10/27/21 End: 12/18/21 Due: 12/18/22

To Compare the Pharmacokinetics of Fimasartan/Amlodipine Combination Tablet and Coadministration of Fimasartan and Amlodipine as Individual Tablets

Phase: N/A Priority: Normal
NCT ID: NCT02205151 Org: User:
Start: 07/31/14 End: 09/30/14 Due: 09/30/15

Cilnidipine Effect on High Blood Pressure and Cerebral Perfusion in Ischemic Stroke Patients With Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00325637 Org: User:
Start: 01/31/05 End: 08/31/07 Due: 08/31/08

Good Choice of pALliative Chemotherapy to Patient With Pancreatic Cancer ; GemcitAbine Therapy vs FOLFORINOX therapY

Phase: N/A Priority: Normal
NCT ID: NCT04789980 Org: User:
Start: 01/29/21 End: 01/29/25 Due: 01/29/26

A Study to Evaluate the Efficacy and Safety of BR1015 Combination Therapy

Phase: N/A Priority: Normal
NCT ID: NCT05878561 Org: User:
Start: 11/09/22 End: 12/02/24 Due: 12/02/25

A Study to Evaluate the Effect of Ketoconazole and Rifampicin on the Pharmacokinetics of Fimasartan in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00938262 Org: User:
Start: 04/30/09 End: 08/31/09 Due: 08/31/10

A Study to Compare the Pharmacokinetics of BR4002 and BR4002-1 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT04462029 Org: User:
Start: 06/05/20 End: 10/07/20 Due: 10/07/21

Antihypertensive Efficacy and Tolerability and Determine the Adequate Antihypertensive Dosage of Fimasartan in Mild to Moderate Essential Hypertension Patients

Phase: N/A Priority: Normal
NCT ID: NCT00923611 Org: User:
Start: 09/30/07 End: 06/30/08 Due: 06/30/09

A Clinical Trial to Evaluate the Pharmacokinetics and Safety/Tolerability of Fimasartan and Atorvastatin in Healthy Male Volunteers.

Phase: N/A Priority: Normal
NCT ID: NCT02994745 Org: User:
Start: 12/23/16 End: 08/31/17 Due: 08/31/18

A Combination Drug Including Fimasartan and Statins in Patients With Hypertension and Dyslipidemia

Phase: N/A Priority: Normal
NCT ID: NCT04554953 Org: User:
Start: 04/13/20 End: 05/31/22 Due: 05/31/23

To Evaluate the Immunogenicity and Safety of Inactivated Hepatitis A Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT03654664 Org: User:
Start: 06/20/17 End: 06/24/19 Due: 06/24/20

Combination of Fimasartan/Amlodipine/Rosuvastatin in Patients With Essential Hypertension and Dyslipidemia

Phase: N/A Priority: Normal
NCT ID: NCT03156842 Org: User:
Start: 05/29/17 End: 12/07/18 Due: 12/07/19

Oxaliplatin Adjuvant Chemotherapy After Curative Resection of Primary Colon Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04416490 Org: User:
Start: 03/25/20 End: 02/28/27 Due: 02/28/28

A Study to Compare the Pharmacokinetics and Safety of a Fixed Dose Combination of Fimasartan/Amlodipine/Rosuvastatin

Phase: N/A Priority: Normal
NCT ID: NCT02995720 Org: User:
Start: 08/26/16 End: 05/30/17 Due: 05/30/18

Evaluate the Quality of Life and Treatment of Anxiety Symptoms of Buspirone in Patients With Depression Disorders(BASIS)

Phase: N/A Priority: Normal
NCT ID: NCT04770454 Org: User:
Start: 02/08/21 End: 03/30/23 Due: 03/30/24

A Study to Compare the Pharmacokinetics and Safety/Tolerability of BR-UPS (Ulipristal Acetate) 5 mg Tablet With Inisia (Ulipristal Acetate) 5 mg Tablet

Phase: N/A Priority: Normal
NCT ID: NCT03156127 Org: User:
Start: 05/19/17 End: 10/31/17 Due: 10/31/18

A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1018 and Coadministration of BR1018A and BR1018B in Healthy Adult Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT06889012 Org: User:
Start: 05/01/25 End: 06/26/25 Due: 06/26/26

A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fasting Conditions in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT06008028 Org: User:
Start: 08/10/23 End: 10/06/23 Due: 10/06/24